Cigna Corporation

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +45

Cigna (CI) Stock Still Looks Undervalued On Connected Benefits Launch - simplywall.st

AI-generated analysis

πŸ“ˆ Cigna Group has returned approximately 41.0% over the past five years, framing the stock as a steady compounder.

πŸ“‰ The company currently trades at a P/E ratio of about 11.5x, significantly below the Healthcare industry average of 25.0x and peer average of 31.6x.

πŸ” A high value score of 6 suggests Cigna Group is broadly checked as cheap relative to where the stock currently trades.

πŸ’‘ The Fair Ratio model points to a P/E of 28.7x as a reasonable reference, indicating a wide gap between current multiples and sector benchmarks.

πŸš€ The launch of Connected Benefits aims to support expectations for stronger engagement in Cigna Healthcare products.

⚠️ Ongoing regulatory scrutiny of the pharmacy benefit model can pressure margins and negatively impact investor sentiment.

Bullish Signals
  • Cigna Group has delivered a solid 41.0% total return over the past five years, establishing it as a steady compounder.
  • The stock screens as undervalued on market multiples with a high value score of 6, indicating cheapness relative to current trading levels.
  • Cigna Group trades at a P/E ratio of approximately 11.5x, which is well below the broader Healthcare industry average of 25.0x and peer average of 31.6x.
Risk Factors
  • Ongoing regulatory scrutiny of its pharmacy benefit model poses a risk that could pressure margins and dampen investor sentiment.
Full Analysis
Cigna Group (CI) has delivered a 41.0% total return over the past five years, positioning it as a steady compounder despite recent muted short-term returns. The company is currently trading at a P/E ratio of approximately 11.5x, which stands in stark contrast to the broader Healthcare industry average of 25.0x and peer group average of 31.6x. Simply Wall St analysis indicates that Cigna Group screens as undervalued based on market multiples, with a high value score suggesting the stock is cheap relative to its current earnings power. The Fair Ratio model estimates a reasonable P/E multiple of 28.7x, highlighting a significant valuation gap between the current market price and sector benchmarks. Investors are evaluating whether the recent share price decline offers a reasonable entry point for those focused on fundamental value. While the launch of new products like Connected Benefits aims to drive engagement in Cigna Healthcare, ongoing regulatory scrutiny regarding its pharmacy benefit model presents potential risks that could pressure margins and investor sentiment.